Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors by ALES MLINARIC et al.
Searching for novel inhibitors of the HIV replication cycle is one of the main inter-
ests of numerous investigators and enormous efforts have been dedicated to finding
promising lead compounds, both synthetic and natural (1). HIV-1 reverse transcriptase
(HIV-1 RT) is one of the main targets for inhibiting the reproduction of HIV. This en-
zyme is responsible for transcription of viral RNA into a DNA, which is later integrated
into the host cell and carries the information for the synthesis of new viral particles. In-
hibition of HIV-1 RT, besides the later discovered HIV protease and integrase inhibition,
was the first therapeutic approach successfully applied in prolonging the life of infected
patients (2). Many inhibitors have been and still are intensively discovered in small and
big scale screenings while only a small number is used in therapy. These compounds are
nucleoside and non-nucleoside inhibitors (3).
HIV exhibits a high ability to develop resistance against therapeutic agents and
therefore new promising substances have to be discovered. One of the commonly used
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Extracts obtained using methanol and dichloromethane
from 57 species of wood damaging fungi were investi-
gated for their ability to inhibit HIV-1 reverse transcriptase
activity in vitro using a non-radioactive assay. Sixty-three
samples were tested all together; some species were rep-
resented more than one isolate. Thirteen methanolic ex-
tracts exhibited more than 40% inhibition and two among
them inhibited the enzyme by more than 80%. All extracts
obtained with dichloromethane were inferior to metha-
nolic extracts in their inhibitory activity. The most active
fungal species discovered in the first screening were Lae-
tiporus sulphureus and Poria monticola, followed by Poria
vaillanti and Chondrostereum purpureum. In the second
screening, Laetiporus sulphureus was selected for detailed
examination and different isolates were tested. Prelimi-
nary findings confirmed the presence of an acidic com-
pound with the amino group in the most active fraction.
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methods in discovering new leading compounds is also screening of synthetic and natural
substances. Hence, screening strategies and bioassays have been developed. The early
developed assays to screen for HIV-1 RT inhibitory activity were relatively complicated,
time consuming and included work with radioactive material (4). Recently, a simple,
non-radioactive ELISA based assay became commercially available, and enabled rapid,
reliable and safe screenings with a minimum amount of sample.
Numerous natural inhibitors of HIV-1 reverse transcriptase have been described,
most of them obtained from plants (5–7), but not from fungi. The kingdom of fungal or-
ganisms represents a vast, promising and often overlooked source of novel therapeutic
agents. Especially some lignicolous or woods destructing fungi are common ingredients
of traditional medicines (Lentinus edodes, Trametes spp., Ganoderma lucidum, Coriolus ver-
sicolor) (8). The medicinal purpose for which this type of fungi has been most exten-
sively investigated is their antitumour activity. Antiviral activity was also studied in
some cases (9–12).
In order to find novel therapeutic agents, we decided to perform screenings of some
Slovenian plants and fungi for their potential therapeutic activity (13). Fungal species
currently examined belong to Basidiomycotina and Ascomycotina. All of them are connected
with wood. Among them some species cause white-rot decay, some soft-rot decay, some
species are connected with blue stain, and some species are symbiotic with wood insects
(so-called Ambrosia bugs). To our knowledge, this preliminary study represents the first
attempt to search for HIV-1 RT inhibitors in the wood-damaging fungi.
EXPERIMENTAL
Fungal material
Fungal species that we selected belong to Basidiomycotina (31 species) and Ascomy-
cotina (25 species). Fungi specimens were obtained from the Collection of Wood Fungi of
the Department for Wood Science and Technology, Biotechnical Faculty, University of
Ljubljana (Slovenia) where voucher specimens are deposited. One sample of Laetiporus
sulphureus was obtained from the field (Slovenska Bistrica, Slovenia) and used in the se-
cond screening.
Fungi were grown on the potato-dextrose-agar (PDA) medium (Fluka, Switzerland)
consisting of potato extract (4 g L–1), dextrose (20 g L–1) and agar (15 g L–1) in 9-cm di-
ameter Petri dishes. Medium was prepared by dissolving 39 g of PDA mixture in 1 L of
distilled water and autoclaved (121 °C, 202.6 kPA, 20 min). Samples were incubated at
25 °C and 100% relative moisture until the medium was overgrown with mycelium. Sub-
sequently, the medium and mycelium were freeze-dried.
For the second screening, the most active fungi were grown on the PDA medium, in
liquid malt medium (1%, m/V in water) (malt extract Biolife, Italy) and in the following
liquid medium (g per litre aq-solution): KH2PO4, 0.2, NH4Cl, 0.2, Ca(NO3)2, 0.05, MgSO4
 7H2O, 0.15; FeCl3, 0.12, malt extract, 0.5, glucose, 5). Liquid media were autoclaved af-
ter preparation as stated above.
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Preparation of extracts
Freeze-dried PDA medium with mycelium was pulverised. The powder (500 mg of
each) was extracted with methanol or dichloromethane (10 mL). Extraction procedure
was performed as follows: maceration at room temperature for 30 min, extraction in the
ultrasonic bath for 30 min, maceration at room temperature for 12 h and repetition of the
procedure in the ultrasonic bath. Extracts were filtered and the solvent was evaporated
to dryness under reduced pressure and temperature not exceeding 35 °C. Dry extracts
were dissolved in sterile DMSO (Fluka, 10%, V/V, aqueous solution), diluted to a final
concentration of 1 mg mL–1 and tested immediately. DMSO was used as a solvent in-
stead of methanol because of its lower inhibitory activity towards HIV-1 RT.
In the case of liquid medium, a mixture of mycelium and medium was separated by
filtration and both fractions were freeze-dried, extracted with 50% (V/V) and pure meth-
anol and prepared for testing as described above.
Extracts of freeze-dried fresh media, prepared as described, were used as negative
controls.
HIV-1 RT assay
Reverse Transcriptase Assay, non-radioactive (No. 1 468 120), was purchased from
Roche Diagnostics (Switzerland). The assay was performed according to the manufac-
turer’s instructions. HIV-1 RT (recombinant, 2.5 ng dissolved in 20 L of Tris buffer: 50
mmol L–1 Tris, 80 mmol L–1 KCl, 2.5 mmol L–1 DTT, 0.75 mmol L–1 EDTA dissolved in
0.5% Triton® X-100, pH 7.8) and the sample dissolved in DMSO (20 L) were added to a
microtiter plate well. The reaction was started with addition of 20 mL of the reaction
mixture containing RNA template/primer hybrid, DIG-dUTP, biotin-dUTP and dTT nu-
cleotides. The mixture was incubated for 1 h at 37 °C. The microtiter plate was washed
five times with 200 L of washing buffer, and subsequently 20 L of anti DIG-POD con-
jugated antibodies dissolved in sodium phosphate buffer pH 7.4 (Roche) were added.
The mixture was incubated again for 1 h at 37 °C. After the incubation period, the wells
were washed with 200 L of washing solution (Roche, composition not disclosed). Later
on, 250 L of ABTS substrate was added (ABTS dissolved in phosphate buffer contain-
ing sodium perborate and citric acid, Roche). Absorbance was measured after 15 min-
utes with a Biolise Rainbow (Tecan, Austria) microtiter plate reader at 405 nm. The inhi-
bition rates were calculated by comparison with the sample-free control and corrected
by comparison with the enzyme-free control.
Preparative HPLC
Separation of the most active extract was performed by preparative HPLC (prepara-
tive column: Eurospher 100 C18 5 mm, length 120 mm, diameter 16 mm, injector Midas
Spark, pumps: Knauer-HPLC pump K-501, mixing chamber: Knauer, fraction collector:
Bio-Rad, model 2128). Gradient elution was performed starting with 12% methanol in
water (15 min), continuing with gradient (12–50% methanol) for 10 min and ending with
12% methanol for 5 min. Injection volume (sample) was 250 L, flow rate was 4 mL
min–1. Fractions were collected at 1 minute intervals and fractions were evaporated to
dryness in vacuo.
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TLC and identification
Thin-layer chromatography was performed on Kieselgel 60 and Kieselgel 60 F254
(Merck, Germany) plates using mobile phase containing dichloromethane and methanol
(9:1) and different spraying reagents such as FeCl3 (32), vaniline solution in H2SO4 (32),
anysaldehide (32), rodamin G6 (32), nynhidrine and bromcresol green (32).
RESULTS AND DISCUSSION
In the first screening total of 63 samples were tested because some species were rep-
resented by a larger number of isolates.
The experimental results, presented in Table I, indicate that the methanolic extracts
of 13 samples and dichloromethane extracts of only 1 sample exhibited more than 40%
in vitro inhibition of HIV-1 reverse transcriptase. Dichloromethane extracts were inferior
to methanolic extracts in their inhibitory activity. This may be due to the presence of ac-
tive polar inhibitory compounds in investigated methanolic extracts. In Table II, inhibi-
tory activity of the most active extracts is presented.
The most active Ascomycotina species were Cladosporium herbarum, Leptographium
lundbergii and Pichia anomala with inhibitory activities of their methanolic extracts of
50.7%, 54.7% and 48.7%, respectively. No HIV and general antiviral activity was previ-
ously reported for these three moulds. The only available reference of chemical composi-
tion of Leptographium lundbergii notes the presence of africanols, sesquiterpene derivatives
(29) with no biological activity described. The sponge derived Cladosporium herbarum
contains macrolide substances pandangolides and cladospolides, which have phytotoxic
activity. The presence of antimicrobial furane carboxylic acids was also reported (14) but
these data may not correspond with our data obtained for the strain, which was isolated
from wood. Pichia anomala is the producer of a killer toxin (PaKT) with known antimi-
crobial properties (15) and may also be responsible for the anti HIV-RT activity discov-
ered in our study.
The Basidiomycotina member with outstanding activity was Laetiporus sulphureus, whose
inhibitory activity was 90.1%. There is no published data concerning this fungi and its
anti-HIV activity. The most significant pharmacological activity of the extract obtained
from L. sulphureus, which was observed by Okamura (16), is the inhibition of thrombin. The
substance responsible for this activity has not been reported to date. Chemical composition
of this fungi was partly reported by Rapior (17) who searched for volatile compounds
and discovered twenty-six components. The major constituents were 3-methylcinnamal-
dehyde, 2-phenylethanol, benzaldehyde and N-phenylethylformamide. He also identi-
fied some sulphur compounds, which may be responsible for the odour of L. sulphureus.
A cyclodepsipeptide beauvericin with antimicrobial activity was also isolated from L.
sulphureus (30). This fungus was also reported to cause hallucinations and atoxia in chil-
dren upon ingestion. Two triterpenoids, 15-hydroxytrametenolic acid and sulfurenic
acid, showed dopamine D2 receptor agonistic activity in monkeys (30). The most recent
discovery was laetiporic acid, a new polyene pigment. No pharmacological activity was
reported yet (31). In one report (18), the isolation of a new benzofurane glycoside, masu-
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Ascomycotina Alternaria alternata (Fr.: Fr.) von Keissler – –
Ascomycotina Aspergillus terreus Thom – –
Ascomycotina Calcarisporium arbuscula Preuss – –
Ascomycotina Ceratocystis coerulescens (Münch) Bakshi + +
Ascomycotina Chaetomium globosum (Kunze: Fr.) – +
Ascomycotina Cladosporium herbarum (Pers.) Link: Fr. ++ +
Ascomycotina Epicoccum nigrum Link – –
Ascomycotina Gilmaniella humicola Barron – +
Ascomycotina Hormonema dematioides Lagerberg & Melin – –
Ascomycotina Humicola grisea Traaen – –
Ascomycotina Hymenula cerealis Ellis & Everh. + –
Ascomycotina Leptographium lundbergii Lagerberg & Melin ++ +
Ascomycotina Nectria vilior Starb. – –
Ascomycotina Ophiostoma araucarie – –
Ascomycotina Ophiostoma piliferum (Fr.: Fr) H. & P. Sydow – –
Ascomycotina Phialophora aurantiaca – –
Ascomycotina Phialophora mutabilis (van Beyma)
Schol-Schwartz
+ –
Ascomycotina Pichia anomala (Hansen) Kurtzman ++ +
Ascomycotina Raffaelea ambrosia – –
Ascomycotina Sclerophoma pythiophila (Corda) Höhn. – –
Ascomycotina Scytalidium album (isolate 2a) – –
Ascomycotina Sporotrichum pulverulentum Novobranova – –
Ascomycotina Trichoderma harzianum Rifai – +
Ascomycotina Tricholus spiralus + –
Ascomycotina Verticillium lecanii (Zimm.) Viegas + –
Basidiomycotina Agrocybe aegerita (Brig.) Fayod – –
Basidiomycotina Antrodia vaillanti (Fr.) Ryv. (isolate 4) ++ ++
Basidiomycotina Aureobasidium pullulans (de Bary) Arnaud
(isolate 2)
– –
Basidiomycotina Bjerkandera adjusta (Willd.: Fr.) Karst + –
Basidiomycotina Chondrostereum purpureum (Pers.: Fr.) Pouz.
(isolate 1)
++ –
Basidiomycotina Chondrostereum purpureum (isolate 2) + –
Basidiomycotina Chondrostereum purpureum (isolate 3) – –
Basidiomycotina Chondrostereum purpureum (isolate 4) ++ –
Basidiomycotina Coniophora puteana (Schum.: Fr.) Karst. + +
Basidiomycotina Creolophus cirrhatus (Pers.: Fr.) Karst. – –
Basidiomycotina Daedalea quercina (L.: Fr.) Pers. + +
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Basidiomycotina Daedaleopsis confragosa (Bolt.: Fr.) Schroet. – –
Basidiomycotina Flammulina velutipes (Curt.: Fr.) Karst. – –
Basidiomycotina Fomitopsis pinicola (Sow.: Fr.) Karst. + –
Basidiomycotina Ganoderma applanatum (Pers.) Pat. – –
Basidiomycotina Ganoderma lucidum (Leyss.: Fr.) Karst. – –
Basidiomycotina Gloeophyllum trabeum (Pers.) Murr. (isolate 2) + –
Basidiomycotina Grifola frondosa (Dicks.: Fr.) Gray – –
Basidiomycotina Heterobasidium annosum (Fr.: Fr.) Bref. – –
Basidiomycotina Laetiporus sulphureus (Bull.: Fr.) Murrill +++ +
Basidiomycotina Lentinula edodes (Berk.) Pegl. – –
Basidiomycotina Marasmius stiptitarius – –
Basidiomycotina Peniophora gigantea (Fr.) Massee – –
Basidiomycotina Pholiota adiposa (Fr.) Kumm. + –
Basidiomycotina Pleurotus ostreatus (Jacq.: Fr.) Kumm. (isolate 2) – –
Basidiomycotina Pleurotus ostreatus (isolate 3) – –
Basidiomycotina Poria monticola (isolate 2) +++ +
Basidiomycotina Poria vaillanti (DC. & Lamarck) Fries (isolate 1) ++ +
Basidiomycotina Poria vaillanti (isolate 2) ++ +
Basidiomycotina Schizophyllum commune (Fr.: Fr.) (isolate 2) – +
Basidiomycotina Serpula lacrymans (Wulf.: Fr.) Schroet. (isolate 2) + +
Basidiomycotina Serpula lacrymans (isolate 4) + –
Basidiomycotina Sistostrema brinkmannii (Bres.) Erikss. ++ –
Basidiomycotina Stereum hirsutum (Wild.: Fr.) Fr. + +
Basidiomycotina Stereum rugosum (Pers. ex Fr.) Fr. ++ +
Basidiomycotina Stereum subtomentosum (Pouz.) ++ +
Basidiomycotina Trametes gibbosa (Pers.: Fr.) Fr. + +
Basidiomycotina Trametes versicolor (L.: Fr.) Lloyd (isolate 2) – –
+++ > 80% inhibition, ++ 40–80% inhibition, + < 40% inhibition, – no inhibition
a Certain species are represented by a larger number of isolates in the Wood fungi collection of the Depart-
ment for Wood Science and Technology (Biotechnical Faculty, University of Ljubljana, Slovenia).
Table II. In vitro HIV-1 RT inhibitory activity of methanolic extracts (first screening)
Species Inhibition (%)a
Chondrostereum purpureum (isolate 1) 64.3 ± 4.8
Chondrostereum purpureum (isolate 4) 62.3 ± 5.0
Cladosporium herbarum 50.7 ± 4.3
Laetiporus sulphureus 90.1 ± 3.6
Leptographium lundbergii 54.7 ± 7.0
Pichia anomale 48.7 ± 3.9
Poria monticola (isolate 2) 86.1 ± 8.4
Poria vaillanti (isolate 2) 53.3 ± 2.1
Poria vaillanti (isolate 1) 68.7 ± 5.2
a Mean ± SD, n = 3.
takeside I and a new acetylenic acid, masutakic acid, from the fruiting bodies of L. sul-
phureus var. miniatus that grows in Japan was reported. No biological activity of these
substances was reported. Zjawiony (30) reported in his recent review that compounds
such as egonol, demethoxyegonol and egonol glucoside, all isolated from L. sulphureus
var. miniatus, exhibited low cytotoxic activity.
The second most active species was Poria monticola (isolate 2), whose inhibitory ac-
tivity of HIV-1 RT was 86.1%. The related species Poria vaillanti and P. vaillanti (isolate 2)
showed 68.7% and 53.3% inhibition, respectively. A sample of the same species, stored
under the synonym Antrodia vaillanti (isolate 4) showed similar inhibition as P. vaillanti.
The sample of Poria monticola (isolate 2) was further diluted and tested in dilutions of 0.1
and 0.01 mg mL–1, which showed inhibitions of 42.4% and 16.4%, respectively. This spe-
cies is relatively abundant in Europe and is known under numerous synonyms (Poria
placenta, Oligoporus placenta, Tyromyces placenta). It causes brown rot decay, mostly on
softwood constructions in buildings. Poria species degrade cellulose, leaving a brown
residue of lignin. Until this research, there were no reports of therapeutic uses of Poria
monticola. Reports of its chemical constitution are scarce. The presence of volatile metabo-
lites such as acroleine, butanal, octanal, acetone and some terpenes was reported in one
study but these compounds may also be connected with the specific source from which
this fungus was isolated (19). P. monticola also produces oxalic acid and hydrogen perox-
ide, which are believed to be involved in the degradation of wood carbohydrates (20).
Popular medicinal fungi, such as Ganoderma applanatum, Ganoderma lucidum, Grifola
frondosa, Lentinula edodes and Trametes versicolor, did not exhibit HIV-1 RT inhibitory ac-
tivity in our in vitro test, although many reports of their antiviral activity exist in the lite-
rature. The authors reported inhibition of the binding of HIV with lymphocites, caused
by the polysaccharides isolated from T. versicolor, as one of the mechanisms of antiviral
activity (30). According to Chihara (21), a lentinan compound, obtained from Lentinus
edodes, enhanced host resistance to infections by bacteria as well as by fungi, parasites
and viruses, including the agents of AIDS. Lentinan reduced the toxicity of azidothy-
midine (HIV-1 RT inhibitor used in therapy). Prevention of the onset of AIDS symptoms
through potentiation of host defence was also described (21, 22). Antiviral activity of
water and methanol soluble substances from Ganoderma lucidum was reported (9). Iso-
lated substances were estimated to be polysaccharides and proteins and were inhibitory
to Herpes simplex virus (HSV-1 and HSV-2) (9). Triterpenes, especially ganoderic acid b,
isolated from fruiting bodies of Ganoderma lucidum, exhibited HIV protease inhibitory
activity (23, 30). The same species also produced compounds the ganoderiol F and ga-
nodermanotriol, which have anti-HIV-1 activity (30). Although a report on HIV reverse
transcriptase inhibiton caused by cerebrosides isolated from G. lucidum was published
(24), we did not observe such activity. This fact may also be connected with solvents
used for extraction of fungi in our study.
It appears that genus Stereum would be also interesting for further investigation be-
cause both methanolic and dichloromethane extracts of the three tested species were ac-
tive, although not remarkably, and may contain common inhibitory compound(s). We
have not found any previous reports of the anti HIV activity of the tested species S.
hirsutum, S. rugosum and S. subtomentosum. There are many reports on the chemical com-
position of S. hirsutum, which is known for its antimicrobial, antitumour, antioxidant
and phytotoxic activities (25–27).
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Another interesting species is Sistostrema brinkmanii, with inhibitory activity of me-
thanolic extract reaching 48.2%. There are no scientific data about this fungus, obtainable
from the available sources. Interesting aspects were the differences in inhibitory activity
between different isolates of the same species, Chondrostereum purpureum. Methanolic ex-
tracts of isolate 1 and of isolate 4 exhibited inhibitions of 64.3% and 62.3%, while inhibi-
tion of isolate 2 was 12.7% whereas isolate 3 did not show any inhibitory activity. This
species contains sterpurene sesquiterpenes (28) with phytotoxic activity.
In an effort to confirm anti-HIV-1 RT activity and clarify the nature of the most ac-
tive extracts, further investigations were performed in our laboratory. In the second scre-
ening, the most active species were grown on PDA and liquid media. Results of the sec-
ond screening are shown in Table III. Liquid media were separated from the mycelium,
separately extracted and tested. In the latter case, we were able to quantify and compare
more precisely the amount of mycelia used for extraction. In the second screening, three
isolates of Laetiporus sulphureus, among them one obtained from the field, and one iso-
late of Poria monticola (in concentrations of 1.0, 0.01 and 0.001 mg mL–1) were tested. Ac-
cording to this screening, Laetiporus sulphureus was chosen for further research. It was
evident that aqueous-methanolic extracts were more potent than the methanolic ones.
The most potent extract obtained from L. sulphureus (obtained from the field) was ana-
lysed by preparative HPLC; 5 fractions were collected and tested for inhibitory activity
(results shown in Table IV). The most active fraction, namely fraction 1, was analysed by
TLC and preliminarily tested for the presence of different compounds. Tests with FeCl3,
vaniline and rodamin G6 were negative and we concluded that no compounds with a
phenolic hydroxyl group, terpenoid and phenylpropanoid structure and no lipids were
present. The test with anysaldehyde was positive, but due to the unspecific nature of
this reagent, no detailed conclusions could be made. Spraying with bromcresol green re-
vealed the presence of acidic compounds and the test with ninhydrin confirmed the pre-
sence of compounds with an amino group in the most active fraction.
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Table III. In vitro HIV-1 RT inhibitory activity (2) of the most active extracts (second screening)
Extract concentrations (mg mL–1)a
Species Solvent 1.0 0.01 0.001
Laetiporus sulphureus
(from the field)















60.32 ± 6.32 36.10 ± 5.89 24.14 ± 3.30
Poria monticola (isolate 2) MeOH 70.30 ± 7.20 13.84 ± 4.08 8.90 ± 5.03
Poria monticola (isolate 2) MeOH
(50%)
27.70 ± 4.88 12.35 ± 5.56 3.21 ± 5.34
a Mean ± SD, n = 3.
b Used for fractionation by HPLC.
CONCLUSIONS
It would be premature to speculate about the possible mechanism of the reverse
transcriptase inhibition at this stage of research. Both competitive and non-competitive
specific inhibitors may be present, or non-specific inhibitors that would change the sec-
ondary or tertiary structure of the enzyme.
Direct extracts (without any subsequent purification and enrichment) of Laetiporus
sulphureus and Poria monticola with 90% inhibition of HIV-1 RT, and also of Poria vaillanti
and Chondrostereum purpureum showed remarkable activity. More detailed preliminary
examination of Laetiporus sulphureus confirmed the possible presence of an acidic com-
pound with amino group in the most active fraction of the methanolic extract.
Further detailed investigations will be performed in the future to reveal the struc-
ture of inhibitory compound(s).
Abbreviations. – ABTS – 2,2’-azino-bis (3-ethylbenzthialzoline-6-sulfonic acid), anti
DIG-POD – anti digoxigenine-peroxidase, DIG-dUTP – digoxigenine-deoxyuridine tri-
phosphate, dTT – deoxythymidine triphosphate, ELISA – Enzyme-Linked Immunosorbent
Assay, HIV – Human Immunodeficiency Virus, HSV – Herpes Simplex Virus, PDA – po-
tato-dextrose-agar, RT – reverse transcriptase.
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S A @ E T A K
Iskanje inhibitorjev HIV-1 reverzne transkriptaze v lesnih glivah
ALE[ MLINARI^, JAVOR KAC in FRANC POHLEVEN
Iz 57 vrst lesnih gliv sta bili pripravljeni dve seriji izvle~kov. V prvi so bili izvle~ki,
pripravljeni z metanolom, v drugi pa z diklorometanom. Preizku{enih je bilo 63 vzorcev,
saj so bile nekatere vrste zastopane z ve~jim {tevilom izolatov. Izvle~kom smo in vitro
preizkusili inhibitorno aktivnost na HIV-1 reverzno transkriptazo s pomo~jo neradioak-
tivne metode. 13 metanolnih izvle~kov je inhibiralo encim ve~ kot 40-odstotno, med
njimi sta dva inhibirala encim ve~ kot 80-odstotno. Najbolj u~inkovita sta bila izvle~ka
gliv Laetiporus sulphureus in Poria monticola, sledita jim izvle~ka vrst Poria vaillanti in
Chondrostereum purpureum. V nadaljevanju raziskave smo ugotavljali inhibitorno aktiv-
nost razli~nih izolatov glive Laetiporus sulphureus. Najbolj aktivne izvle~ke smo frakcio-
nirali s pomo~jo preparativne teko~inske kromatografije. Domnevamo, da bi bila lahko v
najbolj aktivni frakciji prisotna spojina ali spojine, ki so kisle narave in imajo v strukturi
amino skupino.
Klju~ne besede: HIV-1 reverzna transkriptaza, re{etanje, glive, Laetiporus sulphureus
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